Pets at Home’s vet business cushions FY26 profit decline

Pets at Home’s FY26 results show a familiar split in the pet care market: veterinary services kept growing, while retail profitability weakened. The company reported group consumer revenue of £1.981 billion for the 52 weeks ended March 26, 2026, up 1.0% year over year, but underlying profit before tax dropped 30.2% to £92.8 million. Vet Group consumer revenue rose 5.0% to £688.1 million, helping offset a 1.0% decline in retail consumer revenue. (investegate.co.uk)

That gap has been building for some time. Earlier FY26 updates showed the vet segment consistently outpacing retail, with management leaning on the business’s joint venture practice model, care plan growth, and practice expansion to support earnings while the retail arm worked through weaker discretionary demand and price investment. In FY25, Pets at Home had already framed insurance as a major adjacent growth opportunity and said it planned a Pets-branded proposition for the roughly £2 billion UK pet insurance market; by its Q1 FY26 update, the company said that business remained on track for a 2026 launch. (globalpetindustry.com)

The headline numbers from FY26 make the contrast clearer. Retail underlying profit before tax fell 57.8% to £30.8 million, while Vet Group underlying profit increased 10.4% to £83.8 million. Free cash flow from the vet business rose 9.9% to £74.2 million, versus just £2.7 million from retail. Pets at Home said vet growth was driven by strong Care Plan sign-ups and higher average transaction values, and it finished the year with 407 joint venture practices and 48 company-managed practices. Management said average practice revenue reached about £1.5 million, and that the group accelerated vet openings to eight in FY26, with plans to step up again in FY27. (investegate.co.uk)

Management’s commentary suggests the company sees veterinary services as the group’s stabilizer. In the earnings presentation, CEO James Bailey said the practices are “the most productive in the sector,” while CFO Sarah Pollard said the “strong structural economics of vets” remained resilient even as the retail business underperformed. The company also highlighted the capital-light nature of the joint venture model, noting that most expansion funding comes from practice partners rather than the group itself. Those comments are self-interested, but they align with the reported mix shift in profits and cash generation. (marketbeat.com)

There’s also a regulatory backdrop. Pets at Home said it welcomed the UK Competition and Markets Authority’s final report on the veterinary services market, which the company said recognized its practices as offering competitive prices and strong customer outcomes within a differentiated joint venture structure. The CMA’s own March 24, 2026 announcement, however, was broader and more cautionary: it concluded that competition concerns exist across the market and said legally binding reforms, including price lists, prescription fee caps, a price comparison website, and clearer branding for large groups, will begin coming into force later in 2026. (investegate.co.uk)

Why it matters: For veterinary professionals, Pets at Home’s results are another sign that practice-linked recurring revenue and service utilization remain attractive even when broader pet spending is uneven. The numbers also highlight how large multi-service groups are increasingly using veterinary operations not just as an add-on, but as a core earnings engine. That has implications for recruitment, consolidation, pricing transparency, and the competitive position of independent practices. At the same time, the CMA’s remedies could reshape how large groups present prices, subscriptions, and group branding to pet parents, which may affect client communication workflows inside practices. (investegate.co.uk)

For veterinary teams specifically, the joint venture model is worth watching because Pets at Home continues to present it as both scalable and cash generative. The company said 70% of its pet care centers now have a vet practice, suggesting more co-located clinical capacity and continued network density. If the model keeps delivering profit growth while retail remains under strain, that could reinforce further investment in practice openings, extensions, technology, and care-plan-led retention. (investegate.co.uk)

What to watch: In FY27, the key questions are whether vet revenue growth re-accelerates after a softer Q4, how quickly CMA remedies change day-to-day operations for large groups, and whether Pets at Home’s insurance buildout becomes a meaningful cross-sell alongside care plans and clinical services. Management has already cautioned that veterinary revenue growth may be more subdued in the near term, even as profit growth is expected to continue. (marketbeat.com)